BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4791486)

  • 21. Activity of cephazolin and other cephalosporins against Bacteroides fragilis.
    Leigh DA; Simmons K
    Scott Med J; 1976 Sep; 20(5):228-31. PubMed ID: 1265472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the in vitro activity of several cephalosporin antibiotics against gram-negative and gram-positive bacteria resistant to cephaloridine.
    Kisch AL; Bartholomew L
    Antimicrob Agents Chemother; 1976 Sep; 10(3):507-10. PubMed ID: 984793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five cephalosporins: pharmacokinetics and their relation to antibacterial potency.
    Sohn C; Pitkin D; Grappel S; Zajac I; Actor P; Alexander F; Lentnek A; Wikler M; Stote R; Dubb J
    Clin Ther; 1984; 6(4):560-70. PubMed ID: 6467282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic antibiotics for women undergoing vaginal hysterectomy.
    Lett WJ; Ansbacher R; Davison BL; Otterson WN
    J Reprod Med; 1977 Aug; 19(2):51-4. PubMed ID: 330851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which cephalosporin?
    Chambers ST
    N Z Med J; 1992 Dec; 105(947):498-500. PubMed ID: 1461609
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro comparison of cefazolin with other cephalosporins.
    Yeivin R; Meshulam M; Sacks T
    Isr J Med Sci; 1974 Sep; 10(9):1092-5. PubMed ID: 4436031
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral and parenteral cephalosporins: the place of cephalexin in antibacterial therapy.
    Finland M
    Drugs; 1972; 3(1):1-8. PubMed ID: 5053818
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of penicillin and cephalosporin antibiotics in the treatment of pyogenic infection].
    Govorovich EA; Marshak AM; Iakovlev VP; Lunacharskaia TV
    Sov Med; 1972 Feb; 35(2):48-51. PubMed ID: 5039425
    [No Abstract]   [Full Text] [Related]  

  • 29. BL-S640, a cephalosporin with a broad spectrum of antibacterial activity: bioavailability and therapeutic properties in rodents.
    Leitner F; Chisholm DR; Tsai YH; Wright GE; Deregis RG; Price KE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):306-10. PubMed ID: 1137382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sense and nonsense in antibiotic treatment].
    Naumann P; Hubmann R
    Urologe A; 1972 Jan; 11(1):8-12. PubMed ID: 4481991
    [No Abstract]   [Full Text] [Related]  

  • 31. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.
    Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL
    Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind comparison of cephacetrile with cephalothin-cephaloridine.
    Jackson GG; Riff LJ; Zimelis VM; Daood M; Youssuf M
    Antimicrob Agents Chemother; 1974 Mar; 5(3):247-54. PubMed ID: 4599121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.
    Leitner F; Misiek M; Pursiano TA; Buck RE; Chisholm DR; DeRegis RG; Tsai YH; Price KE
    Antimicrob Agents Chemother; 1976 Sep; 10(3):426-35. PubMed ID: 984784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefazolin in the treatment of bacterial pneumonia.
    Turck M; Clark RA; Beaty HN; Holmes KK; Karney WW; Reller LB
    J Infect Dis; 1973 Oct; 128():Suppl:S382-5. PubMed ID: 4147579
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of MDL 19,592, an oral cephalosporin.
    Erickson RC; Baumann RJ; Gibson CB; Hoffman PF
    J Antibiot (Tokyo); 1983 Oct; 36(10):1345-56. PubMed ID: 6605961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cephalosporin antibiotics from microbiologic viewpoint. A comparison of antibacterial and pharmacokinetic properties].
    Naumann P
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):85-92. PubMed ID: 1095503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
    Hsieh CC; Lee CH; Hong MY; Hung YP; Lee NY; Ko WC; Lee CC
    Int J Antimicrob Agents; 2016 Dec; 48(6):712-718. PubMed ID: 27836382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.
    Bran JL; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1972 Jan; 1(1):35-40. PubMed ID: 4596741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.